Complement and Cardiovascular Risk in Adolescents

Completed

Conditions studied: Cardiovascular Disease, Type 2 Diabetes

In brief

This study evaluates how genetic variations in complement, a part of the immune system, affect cardiovascular risk in adolescents.

Key facts

Study ID

NCT02821104

Run by

Ohio State University

People needed

77

Starts

2016-06-01

Expected to finish

2018-06-30

Last updated by the study team

2021-06-11

Who can join

Age: 12 and older, up to 18. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy adolescents age 12 to 18 years
• Medication free for 2 weeks except oral contraceptives in females
• Non Hispanic white

You may not qualify if…

• Chronic medications except for contraceptives in females.
• History of autoimmune disease either endocrine or connective tissue type
• History of hematologic or renal disease, malignancy or other chronic disease
• Hispanic ethnicity,
• African-American or Asian race

Where it is running

• Ohio State University — Columbus, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.